Janus Global Life Sciences Fund (JAGLX)
Sector Experts Seeking Growth and Innovation in Health Care

SHARE CLASS

FUND FACTS (JAGLX)

Inception Date12/31/1998
NAV (As of 4/24/15 )$62.42
Total Net Assets (As of 3/31/15)$4.31B
Annual Expense Ratio
(As of fiscal year end 9/30/14)
GROSS 0.93%
NET 0.93%

Performance (As of 3/31/15)
1 Year42.40%
3 Year37.04%
5 Year26.97%
10 Year15.75%
Morningstar (As of 3/31/15)
CategoryHealth
Overall Rating™
(Based on risk-adjusted returns)

View All Ratings

120 Funds Rated
Equity
Style Box

Returns quoted are past performance and do not guarantee future results; current performance may be lower or higher. Investment returns and principal value will vary; there may be a gain or loss when shares are sold. For the most recent month-end performance click here.

PERFORMANCE View Time Period:
As of 4/24/15As of 3/31/15As of 3/31/15As of 3/31/15
Inception: Dec 31, 1998
PRICE1 DAY
RETURN

YTD
1 YR3 YR5 YR10 YRSINCE
INCEPTION
Class T Shares 
$62.42-0.84%18.85%42.40%37.04%26.97%15.75%13.16%42.40%37.04%26.97%15.75%13.16%42.40%157.36%229.95%331.67%644.80%
MSCI World Health Care Index11.48%20.91%23.95%17.72%10.44%6.41%20.91%23.95%17.72%10.44%6.41%20.91%90.43%126.05%170.00%174.50%
S&P 500® Index3.47%12.73%16.11%14.47%8.01%5.20%12.73%16.11%14.47%8.01%5.20%12.73%56.55%96.50%116.10%127.86%

Returns quoted are past performance and do not guarantee future results; current performance may be lower or higher. Investment returns and principal value will vary; there may be a gain or loss when shares are sold.

Annual Expense Ratio: Gross: 0.93% / Net: 0.93% View Fees and Expenses

RISK STATISTICS
VS. MSCI World Health Care Index

VIEW RISK STATISTICS DEFINITIONS

Alpha
Compares the risk-adjusted performance of a portfolio to a benchmark index.
Beta
A measure of the volatility of a portfolio in comparison to a benchmark index.
R-Squared
Represents the percentage of the portfolio’s performance that can be explained by the general movements of a benchmark index.
Standard Deviation
Measures historical volatility.
Sharpe Ratio
Measures risk-adjusted performance by dividing the portfolio’s excess returns by the standard deviation of those returns.
Information Ratio
Measure of a portfolio management’s performance against risk and return relative to a benchmark or alternative measure.
FUNDINDEX
Alpha11.337.72N/AN/A
Beta0.991.031.001.00
R-Squared (%)57.1471.25100.00100.00
Standard Deviation12.7213.879.7011.34
Sharpe Ratio2.911.942.461.56
Information Ratio1.571.24----

Statistics are for the Fund’s “parent” share class (typically that with the longest history).

MORNINGSTAR PERCENTILEView Time Period:
As of 3/31/15As of 3/31/15
1 YR3 YR5 YR10 YRSINCE
INCEPTION
Percentile Ranking (%)15162330211516233021
Health Category
Rank/Count
19 / 12820 / 12328 / 12235 / 11715 / 7019 / 12820 / 12328 / 12235 / 11715 / 70

CALENDAR YEAR PERFORMANCE

GROWTH OF A $10,000 HYPOTHETICAL INVESTMENT

UP AND DOWN MARKET CAPTURE

AS OF 3/31/153 YR UP MARKET
CAPTURE
3 YR DOWN MARKET
CAPTURE
5 YR UP MARKET
CAPTURE
5 YR DOWN MARKET
CAPTURE
Janus Global Life Sciences Fund139.50%74.31%130.66%88.71%
MSCI World Health Care Index100.00%100.00%100.00%100.00%

Statistics are for the Fund’s “parent” share class (typically that with the longest history).

ANNUAL FEES & EXPENSES

AS OF FISCAL YEAR END 9/30/2014
CLASS T SHARES
Management Fees0.64%
12b-1 FeesN/A
Other Expenses0.29%
Total Gross Expenses0.93%
WaiversN/A
TOTAL NET EXPENSES0.93%